Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

SKP2 Is Dispensable for Normal T-Cell Development but Required for T-Cell Leukemogenesis

Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Huajia Zhang, PhDstudent, Amy Zollman, BS, Angelo A. Cardoso, Nadia Carlesso, MD PhD

Blood (2014) 124 (21): 2214.

https://doi.org/10.1182/blood.V124.21.2214.2214

Published: 2014

Journal Articles

CD166 Identifies Multiple Myeloma Cells That Preferentially Home to the Bone Marrow Microenvironment and Promote Disease Progression and Bone Lytic Disease

Linlin Xu, Christophe Machal, Hao Wu, Colin D Crean, Bradley Poteat, Angelo A. Cardoso, Helmut Hanenberg, Khalid Mohammad, Attaya Suvannasankha, Edward F Srour

Blood (2014) 124 (21): 174.

https://doi.org/10.1182/blood.V124.21.174.174

Published: 2014

Journal Articles

CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche

Brahmananda Reddy Chitteti, Michihiro Kobayashi, Yinghua Cheng, Huajia Zhang, Bradley A. Poteat, Hal E. Broxmeyer, Louis M. Pelus, Helmut Hanenberg, Amy Zollman, Malgorzata M. Kamocka, Nadia Carlesso, Angelo A. Cardoso, Melissa A. Kacena, Edward F. Srour

Blood (2014) 124 (4): 519–529.

https://doi.org/10.1182/blood-2014-03-565721

Published: 2014

Includes: Supplemental data

Journal Articles

Activation Of TLR4-MyD88 Pathway Impairs HSC Function During Acute Inflammation

Huajia Zhang, BS, Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Christen Mumaw, BS, Amy Zollman, BS, Yunlong Liu, Angelo A. Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2013) 122 (21): 2431.

https://doi.org/10.1182/blood.V122.21.2431.2431

Published: 2013

Journal Articles

Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression

Linlin Xu, Christophe Machal, Hao Wu, Bradley Poteat, Colin D. Crean, Angelo A. Cardoso, MD, PhD, John M Chirgwin, PhD, Helmut Hanenberg, MD, Khalid S. Mohammad, M.D. Ph.D., Attaya Suvannasankha, MD, Edward F Srour, PhD

Blood (2013) 122 (21): 3102.

https://doi.org/10.1182/blood.V122.21.3102.3102

Published: 2013

Journal Articles

Loss Of Canonic Notch Signaling In The Microenvironment Causes a Myeloproliferative Syndrome Via Derepression Of The miR155 Promoter

Lin Wang, PhD, Huajia Zhang, BS, Sonia Rodriguez-Rodriguez, PhD, Liyun Cao, PhD, Jonathan Parish, BS, Amy Zollman, BS, Malgorzata Kamocka, PhD, H. Scott Boswell, M.D., Edward F. Srour, Ph.D., Brahmananda Reddy Chitteti, PhD, Taghi Manshouri, Ph.D., Srdan Verstovsek, MD, PhD, Reuben Kapur, PhD, Angelo A. Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2013) 122 (21): 339.

https://doi.org/10.1182/blood.V122.21.339.339

Published: 2013

Journal Articles

Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence

Momoko Yoshimoto, Prashanth Porayette, Nicole L. Glosson, Simon J. Conway, Nadia Carlesso, Angelo A. Cardoso, Mark H. Kaplan, Mervin C. Yoder

Blood (2012) 119 (24): 5706–5714.

https://doi.org/10.1182/blood-2011-12-397489

Published: 2012

Includes: Supplemental data

Journal Articles

STAT3 Is Required for Notch-Induced Leukemogenesis, and Functions As a Critical Survival Effector in T-Cell Leukemia

Jixin Ding, PhD, Ana L. Batista, PhD, Sonia Rodriguez-Rodriguez, PhD, Lin Wang, PhD, Wenjun Zhang, PhD, Akira Moh, PhD, Xin-Yuan Fu, PhD, Weinian Shou, PhD, Nadia Carlesso, MD, PhD, Angelo A Cardoso, MD, PhD

Blood (2011) 118 (21): 920.

https://doi.org/10.1182/blood.V118.21.920.920

Published: 2011

Journal Articles

Activation of the Canonical Notch Signaling Pathway in the Hematopoietic Microenvironment Is Required to Maintain Normal Hematopoiesis

Lin Wang, PhD, Sonia Rodriguez-Rodriguez, PhD, Huajia Zhang, PhD student, Christen Mumaw, BS, Angelo A Cardoso, MD, PhD, Nadia Carlesso, MD, PhD

Blood (2011) 118 (21): 723.

https://doi.org/10.1182/blood.V118.21.723.723

Published: 2011

Journal Articles

Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis.

Rajasubramaniam Shanmugam, PhD., Annique Wilson-Weekes, MS, Hamid Sayar, MD, Attaya Suvannasankha, MD, Angelo A. Cardoso, MD., PhD, Katie J Sargent, RN, Larry D. Cripe, MD, Dhananjaya V Kalvakolanu, PhD., H. Scott Boswell, MD

Blood (2009) 114 (22): 2387.

https://doi.org/10.1182/blood.V114.22.2387.2387

Published: 2009

Journal Articles

Acute Lymphoblastic Leukemia Blast Cells Stimulate the Autocrine Production of CCL2 and IL-8 in Bone Marrow Stromal Cells

Jaira Ferreira de Vasconcellos, BSc, MD, Nilson Ivo Tonin Zanchin, PhD, Angelo A. Cardoso, MD., PhD, Silvia Regina Brandalise, MD, PhD, José Andrés Yunes, PhD

Blood (2008) 112 (11): 2429.

https://doi.org/10.1182/blood.V112.11.2429.2429

Published: 2008

Journal Articles

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-κB

Lara F. Costa, Mercedes Balcells, Elazer R. Edelman, Lee M. Nadler, Angelo A. Cardoso

Blood (2006) 107 (1): 285–292.

https://doi.org/10.1182/blood-2005-06-2208

Published: 2006

Journal Articles

Aberrant Expression of BAFF System Molecules on B-Cell Precursor Leukemia Modulates Tumor Cell Survival: Novel Targets for Therapeutic Intervention.

Sara Maia, Sambasiva P. Rao, PhD, Stephen E. Sallan, MD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 989.

https://doi.org/10.1182/blood.V104.11.989.989

Published: 2004

Journal Articles

mTOR as Therapeutic Target for T-Cell Leukemia: Synergism with Conventional Cytotoxic Drugs and Signaling Inhibitors.

Ana Batista, MSc, Joao T. Barata, PhD, Lara F. Costa, Stephen E. Sallan, MD, Nadia Carlesso, MD, PhD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 521.

https://doi.org/10.1182/blood.V104.11.521.521

Published: 2004

Journal Articles

Crosstalk between Breast Cancer Cells and Bone Marrow Endothelium Require the Engagement of PI3K/AKT Signaling.

Joana G. Brandao, Joao T. Barata, PhD, Raquel Nunes, MD, Lee M. Nadler, MD, Angelo A. Cardoso, MD, PhD

Blood (2004) 104 (11): 1299.

https://doi.org/10.1182/blood.V104.11.1299.1299

Published: 2004

Journal Articles

IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL

Joao T. Barata, Vassiliki A. Boussiotis, Jose A. Yunes, Adolfo A. Ferrando, Lisa A. Moreau, J. Pedro Veiga, Stephen E. Sallan, A. Thomas Look, Lee M. Nadler, Angelo A. Cardoso

Blood (2004) 103 (5): 1891–1900.

https://doi.org/10.1182/blood-2002-12-3861

Published: 2004

Journal Articles

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27 kip1

Joao T. Barata, Angelo A. Cardoso, Lee M. Nadler, Vassiliki A. Boussiotis

Blood (2001) 98 (5): 1524–1531.

https://doi.org/10.1182/blood.V98.5.1524

Published: 2001

Journal Articles

Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells

Paolo Ghia, Pietro Transidico, J. Pedro Veiga, Christoph Schaniel, Federica Sallusto, Kouji Matsushima, Stephen E. Sallan, Antonius G. Rolink, Alberto Mantovani, Lee M. Nadler, Angelo A. Cardoso

Blood (2001) 98 (3): 533–540.

https://doi.org/10.1182/blood.V98.3.533

Published: 2001

Journal Articles

Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage– colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses

Renata Stripecke, Angelo A. Cardoso, Karen A. Pepper, Dianne C. Skelton, Xiao-Jin Yu, Leo Mascarenhas, Kenneth I. Weinberg, Lee M. Nadler, Donald B. Kohn

Blood (2000) 96 (4): 1317–1326.

https://doi.org/10.1182/blood.V96.4.1317

Published: 2000

Journal Articles

Adoptive T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Preclinical Studies

Angelo A. Cardoso, J. Pedro Veiga, Paolo Ghia, Hernani M. Afonso, W. Nicholas Haining, Stephen E. Sallan, Lee M. Nadler

Blood (1999) 94 (10): 3531–3540.

https://doi.org/10.1182/blood.V94.10.3531.422k14_3531_3540

Published: 1999

NARROW

SKP2 Is Dispensable for Normal T-Cell Development but Required for T-Cell Leukemogenesis

CD166 Identifies Multiple Myeloma Cells That Preferentially Home to the Bone Marrow Microenvironment and Promote Disease Progression and Bone Lytic Disease

CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche

Activation Of TLR4-MyD88 Pathway Impairs HSC Function During Acute Inflammation

Role Of CD166 In Multiple Myeloma Cell Homing To The Bone Marrow Microenvironment and Disease Progression

Loss Of Canonic Notch Signaling In The Microenvironment Causes a Myeloproliferative Syndrome Via Derepression Of The miR155 Promoter

Autonomous murine T-cell progenitor production in the extra-embryonic yolk sac before HSC emergence

STAT3 Is Required for Notch-Induced Leukemogenesis, and Functions As a Critical Survival Effector in T-Cell Leukemia

Activation of the Canonical Notch Signaling Pathway in the Hematopoietic Microenvironment Is Required to Maintain Normal Hematopoiesis

Transcriptional Repression of DAPK1 Characterizes a Resistant Phenotype of AML Enforced by Flt3 Signaling and Exclusive Nuclear Abundance of Non-Canonical NFkB2/p52: Synergistic Activity for Flt3 Inhibition along with HDAC Inhibition, or by NFkB Inhibition, for Potentiating ER Stress Apoptosis.

Acute Lymphoblastic Leukemia Blast Cells Stimulate the Autocrine Production of CCL2 and IL-8 in Bone Marrow Stromal Cells

Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-κB

Aberrant Expression of BAFF System Molecules on B-Cell Precursor Leukemia Modulates Tumor Cell Survival: Novel Targets for Therapeutic Intervention.

mTOR as Therapeutic Target for T-Cell Leukemia: Synergism with Conventional Cytotoxic Drugs and Signaling Inhibitors.

Crosstalk between Breast Cancer Cells and Bone Marrow Endothelium Require the Engagement of PI3K/AKT Signaling.

IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL

Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27 kip1

Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells

Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage– colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses

Adoptive T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Preclinical Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only